FDA expands tamiflu use to treat babies under one year old

December 22, 2012
FDA expands tamiflu use to treat babies under 1 year old
Tamiflu can now be given to children as young as 2 weeks old under an expanded approval announced Friday by the U.S. Food and Drug Administration.

(HealthDay)—Tamiflu (oseltamivir) can now be given to children as young as 2 weeks old under an expanded approval announced Friday by the U.S. Food and Drug Administration.

Tamiflu can be used as treatment in children aged 2 weeks to 1 year if they have had for no longer than two days. The drug is not approved to prevent flu in these children and the safety and effectiveness of Tamiflu in children younger than 2 weeks of age has not been established.

While there are fixed dosing regimens for children 1 year and older according to weight categories, dosing for children younger than 1 year must be calculated individually based on exact weight, the FDA stressed. Children 2 weeks to 1 year of age should receive 3 milligrams per kilogram of weight twice daily for five days.

"Pharmacists must provide the proper dispenser when filling a prescription so parents can measure and administer the correct dose to their children," Edward Cox, M.D., M.P.H., director of the Office of in the FDA's Center for Drug Evaluation and Research, said in an FDA news release.

Explore further: Tamiflu touted for child use

More information: More Information

Related Stories

Tamiflu touted for child use

November 16, 2007

The maker of the anti-viral Tamiflu said the drug is effective for treatment and prevention of influenza in young children.

FDA issues Tussionex safety alert

March 11, 2008

The U.S. Food and Drug Administration issued a safety alert, saying incorrect usage of a specific cough medicine can result in serious health risks.

FDA approves first drug for infantile spasms

August 21, 2009

(AP) -- The Food and Drug Administration has approved the first drug to treat infantile spasms, a rare disorder that can cause hundreds of seizures per day in children less than a year old.

FDA panel backs infant doses for kids' Tylenol

May 18, 2011

(AP) -- Federal health experts say dosing instructions for children younger than 2 years old should be added to Children's Tylenol and similar products containing acetaminophen, the popular pain reliever and fever reducer.

Two pancreatic-enzyme products approved

March 2, 2012

(HealthDay) -- Two drugs that supplement the digestion-aiding actions of pancreatic enzymes have been approved by the U.S. Food and Drug Administration, the agency said Thursday in a news release.

Recommended for you

Treatment options for opioid addiction are expanding

August 10, 2016

In the past two decades, the devastation associated with opioid addiction has escaped the relative confines of the inner city and extended to suburban and rural America. Due in large part to the proliferation of prescription ...

Can exercise be replaced with a pill?

October 2, 2015

Everyone knows that exercise improves health, and ongoing research continues to uncover increasingly detailed information on its benefits for metabolism, circulation, and improved functioning of organs such as the heart, ...

FDA bolsters warnings about class of antibiotics

July 26, 2016

(HealthDay)—The U.S. Food and Drug Administration announced Tuesday that it's strengthening label warnings on a class of antibiotics called fluoroquinolones because the drugs can lead to disabling side effects, including ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

cantdrive85
3 / 5 (4) Dec 22, 2012
The poisoning of our children continues...
PeterD
3.7 / 5 (3) Dec 23, 2012
The poisoning of our children continues...

You got that right. Tamiflu is completely worthless, and does nothing to benefit adults, let alone children. The FDA is a criminal organization that should be ended.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.